UNIGE document Scientific Article
previous document  unige:33138  next document
add to browser collection


Published in Revue médicale suisse. 2010, vol. 6, no. 231, p. 56-60,62
Abstract Fracture risk could be evaluated with FRAX. Vitamin D administration decreases the rate of falls and deaths. Denosumab reduces the risk of fracture in postmenopausal women with osteoporosis and shows positive effects in case of breast and prostate cancers with hormone deprivation therapies. Zoledronate and teriparatide alone are more effective than risedronate and alendronate respectively in treatment of glucocorticoids induced osteoporosis. The association zoledronate and teriparatide may be promising. Vertebroplasty is not the first line treatment for symptomatic osteoporotic vertebral fractures. Osteonecrosis of the jaw and subtrochanteric femoral fractures are still events to consider in case of treatments with bisphosphonates.
Keywords Bone Density Conservation Agents/therapeutic useFemaleFractures, Bone/etiology/prevention & controlHumansOsteoporosis, Postmenopausal/complications/drug therapy
PMID: 20196435
Full text
Article (Published version) (626 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-231-page-56.htm
Research group Nutrition et os (66)
(ISO format)
UEBELHART, Brigitte Florence, RIZZOLI, René. Ostéoporose. In: Revue médicale suisse, 2010, vol. 6, n° 231, p. 56-60,62. https://archive-ouverte.unige.ch/unige:33138

342 hits

0 download


Deposited on : 2014-01-10

Export document
Format :
Citation style :